Literature DB >> 3517059

In vitro and in vivo study of stone formation by Corynebacterium group D2 (Corynebacterium urealyticum).

F Soriano, C Ponte, M Santamaría, C Castilla, R Fernández Roblas.   

Abstract

Corynebacterium group D2 inoculated into normal human urine formed struvite crystals and an increase in pH and ammonium concentration after 24 h of incubation. Zinc disks dipped into a broth culture of this microorganism and inserted into the bladders of rats produced stones with a mean weight of 12.5 mg (ranging from 1 to 57.7 mg) after 12 days. Analysis of the infrared spectrum determined the stones to be composed of struvite. From these results its seems that stone formation by Corynebacterium group D2 may be possible both in vitro and in vivo, which may confirm a previous report involving these bacteria in human clinical encrusted cystitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3517059      PMCID: PMC362818          DOI: 10.1128/jcm.23.4.691-694.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Experimental urolithiasis. VIII. Furadantin in treatment of experimental proteus infection with stone formation.

Authors:  C W VERMEULEN; R GOETZ
Journal:  J Urol       Date:  1954-08       Impact factor: 7.450

2.  Medical therapy of experimental infection stones.

Authors:  D L Lamm; S A Johnson; A M Friedlander; R F Gittes
Journal:  Urology       Date:  1977-11       Impact factor: 2.649

3.  Prevention of infected urinary stones by urease inhibition.

Authors:  D P Griffith; D M Musher
Journal:  Invest Urol       Date:  1973-11

4.  Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative.

Authors:  H Takeuchi; K Kobashi; O Yoshida
Journal:  Invest Urol       Date:  1980-09

5.  Antimicrobial susceptibility of Corynebacterium group D2.

Authors:  M Santamaría; C Ponte; I Wilhelmi; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

6.  Inhibition of bacterial urease.

Authors:  D P Griffith; D M Musher; J W Campbell
Journal:  Invest Urol       Date:  1973-11

7.  Stone formation by Ureaplasma urealyticum in human urine and its prevention by urease inhibitors.

Authors:  S Takebe; A Numata; K Kobashi
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

8.  Corynebacterium group D2 as a cause of alkaline-encrusted cystitis: report of four cases and characterization of the organisms.

Authors:  F Soriano; C Ponte; M Santamaria; J M Aguado; I Wilhelmi; R Vela; L C Delatte
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

  8 in total
  26 in total

Review 1.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects.

Authors:  M B Coyle; B A Lipsky
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

2.  In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.

Authors:  A Philippon; F Bimet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

3.  Effects of dietary calcium, magnesium and phosphorus on the formation of struvite stones in the urinary tract of rats.

Authors:  H Takeuchi; M Ueda; M Satoh; O Yoshida
Journal:  Urol Res       Date:  1991

4.  In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.

Authors:  J A García-Rodriguez; J E García Sánchez; J L Muñoz Bellido; T Nebreda Mayoral; E García Sánchez; I García García
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

5.  Skin colonization by Corynebacterium groups D2 and JK in hospitalized patients.

Authors:  F Soriano; J L Rodriguez-Tudela; R Fernández-Roblas; J M Aguado; M Santamaría
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

6.  Emergence of urea-splitting multi-resistant coryneform bacteria (Corynebacterium group D2) as pathogens.

Authors:  F Soriano
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

7.  Isolation of Corynebacterium group D2 from clinical specimens.

Authors:  B Van Bosterhaut; G Claeys; J Gigi; G Wauters
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

8.  Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin.

Authors:  R Fernández-Roblas; S Prieto; M Santamaría; C Ponte; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

9.  Alkaline-encrusted pyelitis and cystitis: an easily missed and life-threatening urinary infection.

Authors:  Siddhartha Lieten; Dan Schelfaut; Karl Martin Wissing; Caroline Geers; Christian Tielemans
Journal:  BMJ Case Rep       Date:  2011-03-29

10.  Incidence and characteristics of urinary tract infections caused by Corynebacterium urealyticum (Corynebacterium group D2).

Authors:  T Nebreda-Mayoral; J L Muñoz-Bellido; J A Garcia-Rodríguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.